Onto Innovation delivered another clean beat-and-raise in the third quarter, yet the stock entered the report down more than 40% since its last one. That gap is the central tension. Non-GAAP earnings of $2.44 per share topped the $2.27 consensus by 6.1% and cleared the $2.30 Earnings Whisper number. Revenue of $409.75 million beat expectations by 4.9%. Earnings grew 165.2% year over year and revenue grew 87.8%, a sharp acceleration from the 41.5% revenue growth for the nine-month period. Fourth-quarter guidance of $430 million to $450 million in revenue and $2.59 to $2.79 in non-GAAP EPS came in above estimates. On the numbers alone, this business is still accelerating.

The quality of the beat mostly holds up. Revenue, operating margin and EPS all exceeded the high end of guidance. Non-GAAP gross margin rose another 60 basis points sequentially to 57.6% and is up 300 basis points year-to-date. Non-GAAP operating margin reached 32.6%, up from 21.1% a year ago. The GAAP picture is noisier. Diluted GAAP EPS of $0.95 was well short of the adjusted figure, largely because of a $40.8 million unrealized loss on the newly acquired Rigaku stake and roughly $12 million in restructuring charges. Investors should also note that operating cash flow of about $79 million trailed non-GAAP net income of $120 million. Inventories climbed to $424 million from $298 million at year-end, and receivables rose to $384 million from $269 million. That working-capital build is consistent with a ramp, but it is worth watching.

The call reinforced how broadly demand is improving. Management's outlook for second-half growth over the first half has risen on every call: above 15% in the first quarter, above 25% in the second and roughly 34% now. Full-year 2026 revenue is tracking near $1.485 billion, above 45% growth, versus the more than $1.3 billion and 30% outlined early in the year. Backlog rose about 20% to more than $1.3 billion, and management cited visibility into customer plans extending into 2027 and 2028. It also guided to sequential revenue growth through at least the first half of 2027. Strength spans multiple product lines:

• Dragonfly G5 is now at more than 10 customers, with 2027 purchase orders already about double 2026 G5 revenue.
• Atlas G6 was described as the fastest OCD launch in company history.
• 3D interconnect revenue year-to-date is more than double last year's total.
• Panel revenue should double in 2026.
• Power and silicon photonics revenue doubled in the quarter.

Management expects both advanced nodes and advanced packaging to grow more than 35% in 2027. No metrics were cut.

Bears still have some legitimate ammunition. Advanced nodes revenue will dip in the fourth quarter after reaching $135 million in Q3. Management called this planned and attributed it to mix shifting toward packaging. Memory and component cost inflation is limiting margin upside, even with gross margin guided to rise about 50 basis points per quarter through 2027. Customer requests to switch orders from G3 to G5 systems require careful inventory management. The Rigaku investment changes the balance sheet as well. The $720 million payment brought cash down to about $1.25 billion, $1.47 billion in 2031 notes now sit on the books, and the stake will be marked to market every quarter, adding GAAP volatility. Analysts pressed on data-center spending and reported HBM push-outs and despecs. Management said it has seen no change in orders, but that is an assurance about the present, not a guarantee.

The market has treated the stock as if those risks matter more than the beat. Shares opened at $300 after the August report, peaked at $353.84 on August 17 and then fell to an inter-earnings low of $155.13 on November 5. At $173.28 heading into the print, the stock was 51% below its quarter high, about 12% above the low and 33% below its 200-day moving average. Investor sentiment weakened from 0.21 to 0.04, essentially neutral, a meaningful cooling of expectations. The Earnings Whispers trend readings are split. Sequential growth and momentum remain positive, while price and AVWAP trends are negative, which mirrors the gap between fundamentals and the tape.

That divergence frames the setup. Expectations entering the print were far lower than in August, while the operating outlook improved on nearly every measure. The question for investors is not whether Onto is executing; it clearly is. The question is whether the AI-driven spending cycle behind its backlog will hold through 2027. The December 17 Analyst Day is the next opportunity for management to add detail to that multi-year view.

The bottom line is that Onto turned in an accelerating quarter with higher guidance, record backlog and widening margins, and management raised nearly every forward metric it tracks. The stock's 42% decline suggests investors are discounting cycle and balance-sheet risks that the reported numbers do not yet show. Those concerns include cost inflation, the advanced nodes air pocket, and Rigaku-related GAAP noise. Until the share price begins to reflect the fundamentals, the gap between the business and the stock remains the defining feature of this name.